Showing results 1 to 20 of 30
next >
| Issue Date | Title | Author(s) |
| Dec-2022 | Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China | Liu, Weiping; Ji, Jie; Zou, Dehui; Cao, Yang; Xu, Yajing; Zhou, Jian; Gao, Sujun; Wang, Fengrong; Chen, Wenming; Du, Juan; Zhou, Hui; Zhou, Fuling; Shi, Jimin; Zhang, Xi; Yang, Jianmin; Jing, Hongmei; Jiang, Zhongxing; Liu, Hui; Li, Caixia; Peng, Hongling; Jiang, Songfu; Wei, Xiaolei; He, Pengcheng; Liu, Yao; Yang, Haiyan; Li, Zengjun; Huang, Xiaobing; Liu, Lin; Shen, Lijing; Liu, Chuanfang; Song, Yuqin; Qiu, Lugui; Wang, Xiaopei; Ma, Jun; Zhu, Jun |
| 2007 | Bortezomib plus thalidomide treatment of newly diagnosed patients-with multiple myeloma - Efficacy and neurotoxicity: Results of a multicenter study | Chen, Shilun; Jiang, Bin; Qiu, Lugui; Yu, Li; Zhong, Yuping; Gao, Wen |
| 2017 | Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China | Shi, Yuankai; Jia, Bo; Xu, Wei; Li, Wenyu; Liu, Ting; Liu, Peng; Zhao, Weili; Zhang, Huilai; Sun, Xiuhua; Yang, Haiyan; Zhang, Xi; Jin, Jie; Jin, Zhengming; Li, Zhiming; Qiu, Lugui; Dong, Mei; Huang, Xiaobing; Luo, Yi; Wang, Xiaodong; Wang, Xin; Wu, Jianqiu; Xu, Jingyan; Yi, Pingyong; Zhou, Jianfeng; He, Hongming; Liu, Lin; Shen, Jianzhen; Tang, Xiaoqiong; Wang, Jinghua; Yang, Jianmin; Zeng, Qingshu; Zhang, Zhihui; Cai, Zhen; Chen, Xiequn; Ding, Kaiyang; Hou, Ming; Huang, Huiqiang; Li, Xiaoling; Liang, Rong; Liu, Qifa; Song, Yuqin; Su, Hang; Gao, Y |
| 16-Oct-2023 | Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies | Song, Yuqin; Wu, Shang-Ju; Shen, Zhixiang; Zhao, Donglu; Chan, Thomas Sau Yan; Huang, Huiqiang; Qiu, Lugui; Li, Jianyong; Tan, Tran-der; Zhu, Jun; Song, Yongping; Huang, Wei-Han; Zhao, Weili; Liu, Herman Sung Yu; Xu, Wei; Chen, Naizhi; Ma, Jun; Chang, Cheng-Shyong; Tse, Eric Wai Choi |
| 2012 | Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial. | Chen, Wenming; Hou, Jian; Zhao, Yaozhong; Qiu, Lugui; Ke, Xiaoyan; Wang, Zhao; Leng, Yun; Jing, Hongmei; Xi, Hao; Zheng, Xiangjun; Wang, Fuxu; Zhu, Bing; Yang, Shifang |
| 2017 | Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study | Leng, Yun; Hou, Jian; Jin, Jie; Zhang, Mei; Ke, Xiaoyan; Jiang, Bin; Pan, Ling; Yang, Linhua; Zhou, Fang; Wang, Jianmin; Wang, Zhao; Liu, Li; Li, Wei; Shen, Zhixiang; Qiu, Lugui; Chang, Naibai; Li, Jianyong; Liu, Jing; Pang, Hongyan; Meng, Haitao; Wei, Peng; Jiang, Hua; Liu, Yan; Zheng, Xiangjun; Yang, Shifang; Chen, Wenming |
| 15-Nov-2022 | Clinical Characteristics and Outcomes of Follicular Lymphoma Patients with Extranodal Involvement: Analysis of a Series of 1090 Cases in China | Lin, Zhijuan; Zha, Jie; Yi, Shuhua; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Fan, Liyuan; Yu, Haifeng; Zheng, Zhong; Xu, Wei; Chen, Feili; Xie, Ying; Chen, Bi-yun; Zhang, Huilai; Wang, Li; Ding, Kaiyang; Li, Wenyu; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing |
| 23-Aug-2021 | Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China | Zha, Jie; Fan, Liyuan; Yi, Shuhua; Yu, Haifeng; Zheng, Zhong; Xu, Wei; Deng, Manman; Lin, Zhijuan; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Chen, Feili; Xie, Ying; Chen, Biyun; Zhang, Huilai; Wang, Li; Ding, Kaiyang; Li, Wenyu; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing |
| 2015 | Continuous Treatment with Lenalidomide and Low-Dose Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma in Asia: Subanalysis of the First Trial | Lu, Jin; Lee, Jae Hoon; Huang, Shang-Yi; Qiu, Lugui; Lee, Je-Jung; Liu, Ting; Yoon, Sung-Soo; Kim, Kihyun; Shen, Zhi Xiang; Eom, HyeonSeok; Chen, Wenming; Min, Chang-Ki; Kim, Hyo Jung; Lee, Jeong Ok; Kwak, Jae Yong; Yiu, Wai; Chen, Guang; Haynes, Annette Ervin; Hulin, Cyrille; Facon, Thierry |
| 2015 | Continuous Treatment with Lenalidomide and Low-Dose Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma in Asia: Subanalysis of the First Trial | Lu, Jin; Lee, Jae Hoon; Huang, Shang-Yi; Qiu, Lugui; Lee, Je-Jung; Liu, Ting; Yoon, Sung-Soo; Kim, Kihyun; Shen, Zhi Xiang; Eom, HyeonSeok; Chen, Wenming; Min, Chang-Ki; Kim, Hyo Jung; Lee, Jeong Ok; Kwak, Jae Yong; Yiu, Wai; Chen, Guang; Haynes, Annette Ervin; Hulin, Cyrille; Facon, Thierry |
| 2017 | Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial | Lu, Jin; Lee, Jae H.; Huang, Shang-Yi; Qiu, Lugui; Lee, Je-Jung; Liu, Ting; Yoon, Sung-Soo; Kim, Kihyun; Shen, Zhi X.; Eom, Hyeon S.; Chen, Wen M.; Min, Chang K.; Kim, Hyo J.; Lee, Jeong O.; Kwak, Jae Y.; Yiu, Wai; Chen, Guang; Ervin-Haynes, Annette; Hulin, Cyrille; Facon, Thierry |
| 2-Nov-2023 | Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma | Zha, Jie; Chen, Qinwei; Zhang, Wei; Jing, Hongmei; Ye, Jingjing; Yu, Haifeng; Yi, Shuhua; Li, Caixia; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Lin, Zhijuan; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing |
| 2018 | Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma | Facon, Thierry; Dimopoulos, Meletios A.; Dispenzieri, Angela; Catalano, John V.; Belch, Andrew; Cavo, Michele; Pinto, Antonello; Weisel, Katja; Ludwig, Heinz; Bahlis, Nizar J.; Banos, Anne; Tiab, Mourad; Delforge, Michel; Cavenagh, Jamie D.; Geraldes, Catarina; Lee, Je-Jung; Chen, Christine; Oriol, Albert; De La Rubia, Javier; White, Darrell; Binder, Daniel; Lu, Jin; Anderson, Kenneth C.; Moreau, Philippe; Attal, Michel; Perrot, Aurore; Arnulf, Bertrand; Qiu, Lugui; Roussel, Murielle; Boyle, Eileen; Manier, Salomon; Mohty, Mohamad; Avet-L |
| 2018 | Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia | Huang, Liang; Liu, Dan; Wang, Na; Ling, Shaoping; Tang, Yuting; Wu, Jun; Hao, Lingtong; Luo, Hui; Hu, Xuelian; Sheng, Lingshuang; Zhu, Lijun; Wang, Di; Luo, Yi; Shang, Zhen; Xiao, Min; Mao, Xia; Zhou, Kuangguo; Cao, Lihua; Dong, Lili; Zheng, Xinchang; Sui, Pinpin; He, Jianlin; Mo, Shanlan; Yan, Jin; Ao, Qilin; Qiu, Lugui; Zhou, Hongsheng; Liu, Qifa; Zhang, Hongyu; Li, Jianyong; Jin, Jie; Fu, Li; Zhao, Weili; Chen, Jieping; Du, Xin; Qing, Guoliang; Liu, Hudan; Liu, Xin; Huang, Gang; Ma, Ding; Zhou, Jianfeng; Wang, Qian-fei |
| 4-Nov-2021 | A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China | Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun |
| 2-Nov-2023 | A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas | Song, Yuqin; Li, Zengjun; Wu, Huijing; Jin, Jie; Zhou, Hui; Zhou, Keshu; Zhang, Liling; Peng, Zhigang; Zhang, Zhiye; Cen, Hong; Jia, Youchao; Shuang, Yuerong; Li, Zhiming; Yang, Haiyan; Zou, Liqun; Li, Zhifeng; Zhang, Zhihui; Li, Junmin; Cao, Junning; Qiu, Lugui; Wu, Shaojie; Gong, Tiejun; Xu, Xiaohong; Wang, Zhen; Zhu, Jun |
| 2014 | A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma | Geng, Chuanying; Hou, Jian; Zhao, Yaozhong; Ke, Xiaoyan; Wang, Zhao; Qiu, Lugui; Xi, Hao; Wang, Fuxu; Wei, Na; Liu, Yan; Yang, Shifang; Wei, Peng; Zheng, Xiangjun; Huang, Zhongxia; Zhu, Bing; Chen, Wen-Ming |
| 2007 | An open-label study of pegylated liposomal doxorubicin, vincristine and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients in Chinese population | Shen, Yang; Shen, Zhixiang; Jiang, Bin; Hou, Jian; Zhan, Rong; Qiu, Lugui; Wu, Yongji; Jin, Jie; Li, Juan; Meng, Fanyi; Zou, Ping; Liu, Ting; Li, Jianyong; Wang, Chun; Wu, Depai; Ma, Jun |
| 15-Apr-2023 | The Oral PI3Kd Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial | Wang, Tingyu; Sun, Xiuhua; Qiu, Lihua; Su, Hang; Cao, Junning; Li, Zhiming; Song, Yuqin; Zhang, Li; Li, Dengju; Wu, Huijing; Zhang, Wei; Li, Junmin; Zhou, Keshu; Zhou, Hui; Yang, Yu; Li, Zhifeng; Cen, Hong; Cai, Zhen; Zhang, Zhihui; Fu, Weijun; Jin, Jie; Li, Fei; Wu, Weixin; Gu, Xuekui; Zhu, Weiliang; Liu, Lihong; Li, Zengjun; Yi, Shuhua; Bao, Hanying; Xu, Zusheng; Qiu, Lugui |
| 15-Jul-2020 | Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20(+) B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study | Jiang, Bo; Ke, Xiaoyan; Zhang, Qingyuan; Xu, Wei; Su, Hang; Huang, Jie; Zhang, Mingzhi; Wang, Huaqing; Jin, Chuan; Zhu, Jun; Liu, Li; Cai, Zhen; Zhao, Xielan; Zhou, Jianfeng; Zhang, Xiaohong; Liu, Jing; Zhou, Hui; Yu, Jie; Sun, Xing; Qi, Junyuan; Qiu, Lugui |
